Physitrack PLC – Interim Report: December 2020 – November 2021 - Seite 2
"Our Q4 2021 results were outstanding. Technological adoption and investment in our space are accelerating, and we continue to grow the business in these exciting times for our market. We have enhanced both our SaaS and our Virtual Care businesses through our acquisitions and through product development, and we look forward to continue on our growth trajectory in 2022."
Financial outlook
As outlined within the IPO prospectus, Physitrack's Board of Directors has adopted a set of financial targets linked to the Company's Strategy as set forth below:
- Growth: Physitrack aims to achieve annual organic sales growth exceeding 30 per cent in the medium term, further supplemented by impact from future add-on acquisitions.
- Margin: Physitrack targets an EBITDA margin of 40-45 per cent in the medium term, with potential short term margin extractions due to add-on acquisitions impacting margins negatively.
There are no changes to these financial targets.
Change of year end
In order to more closely align our financial year end with the purchasing cycles of our customers the Board has made the decision to change the Group's financial year end from 30 November to 31
December. All relevant reporting dates have been updated in the ‘Financial calendar' section of our investor website: https://www.physitrackgroup.com/investors/financial-calendar.
Webcast presentation
A webcast presentation with dial-in possibility will be held at 10.00 a.m. CET today, with CEO Henrik Molin and CFO Charlotte Goodwin. Both the webcast and the telephone conference offer an
opportunity to ask questions. The presentation will be held in English and will be available on https://www.physitrackgroup.com/investors/reports-presentations after the webcast conference.
Webcast link: https://tv.streamfabriken.com/physitrack-group-q4-2020-2021
Dial in details for participants:
SE: +46856642693
UK: +443333009266
US: +16467224903
Enquiries regarding this announcement should be addressed to
Investor contact: Adam Nilsson, +46 (0) 707 46 44 21, ir@physitrack.com
Media contact: Adam Nilsson, +46 (0) 707 46 44 21, media@physitrack.com
About Physitrack
Physitrack, founded in 2012, is a global digital healthcare provider, mainly focused on the B2B physiotherapy and musculoskeletal care market. With staff on four continents, customers in 17 time
zones, and patients in 187 countries, we are a truly global company.